Lubrizol says new materials will bring more TPU to medical devices

By Gayle S. Putrich
Staff Reporter

Published: June 13, 2014 12:06 pm ET
Updated: June 13, 2014 12:14 pm ET

Image By: Lubrizol Corp. Lubrizol Corp. says its new Pathway pharmaceutical-grade excipient will increase the use of thermoplastic polyurethane in implantable drug release devices.

Related to this story

Topics Materials, Medical, Materials Suppliers

NEW YORK — Lubrizol Corp. introduced a medical-grade thermoplastic polyurethane with flame-retardant properties and a new pharmaceutical excipient for implantable controlled-release drug delivery June 10 at the Medical Design & Manufacturing East conference and trade show in New York.

The flame retardant TPU will be part of the Wickliffe, Ohio-based company’s Tecothane line and offered in five different grades, all designed to meet the exacting requirements of health care applications — including ISO 10993-5 test cytotoxicity requirements and sterilization needs — while still enhancing patient comfort, said Robert Miller business development director for Lubrizol LifeScience Polymers.

The new TPU, available in matte, can be processed with injection molding or extrusion and is already getting good reviews from processors, Miller said, “particularly on the feeling — it’s not tacky. No PVC could do this.”

 At the three-day event in New York, Lubrizol also introduced medical device makers to Pathway, a new pharmaceutical-grade excipient aimed at TPU products for implantable controlled drug release devices. Implementing Good Manufacturing Practices (GMP), a pharma standard, at the company’s Wlimington, Mass., facility earlier this year opened the door for the first pharma-grade TPU in addition to Lubrizol’s medical-grade lines, said Joey Glassco, global market manager with Lubrizol LifeScience Polymers.

Drug loading into TPU devices can be achieved with blending and them melt-processing thermally stable drugs and then injection molding or extruding or by dissolving the polymer in compatible solvents — offering more processing versatility than silicone or ethyl vinyl acetate (EVA) competitors, Glassco said. The result is devices ideal for subcutaneous drug delivery systems, such as one that offers 30 to 90 day continuous opiate delivery for helping relive the pain of cancer patients in third-world countries or a variety of vaginal rings delivering birth control or other medications including tenofovir, an anti-microbial proven effective in combating HIV.


Comments

Lubrizol says new materials will bring more TPU to medical devices

By Gayle S. Putrich
Staff Reporter

Published: June 13, 2014 12:06 pm ET
Updated: June 13, 2014 12:14 pm ET

Post Your Comments


Back to story


More stories

Image

Automakers look under the hood for the next lightweighting opportunities

August 20, 2014 1:06 pm ET

The automotive industry's current favorite target for lightweighting efforts is the powertrain, according to a recent survey.    More

Image

ISO publishes international standard for measuring phthalates in toys

August 19, 2014 10:40 am ET

The Geneva-based International Organization for Standardization (ISO) has published an international standard on phthalates used as plasticizers in...    More

Image

RTP expands very long fiber thermoplastic production to Mexico

August 19, 2014 9:47 am ET

RTP Co. has introduced very long fiber reinforced compounds at its Monterrey, Mexico, facility.    More

Image

Ineos takes its first step into UK shale exploration

August 18, 2014 1:15 pm ET

Ineos Group AG has moved into United Kingdom shale exploration with the purchase of BG Group’s 51 percent share of the shale section of a joint ...    More

Image

Construction firm invests in bioplastics maker Meredian

August 15, 2014 10:22 am ET

Bioplastics maker Meredian Inc. didn't have to go far to find a new investor.    More

Market Reports

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report analyzes economic and market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as growth strategies being implemented by thermoformed packaging companies.

Learn more

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

2014 Injection Molding Industry Report

GROWTH, OPPORTUNITY IN SIGHT FOR INJECTION MOLDERS IN 2014

In the wake of the economic turbulence earlier in this decade, molders today find themselves in much better shape. Molders are gaining a competitive advantage by investing in people, equipment and seeking inroads into new markets on a global scale.

Growth in the injection molding industry is going to be driven by low financing costs and a continued move to reshore some business.

Learn more

Upcoming Plastics News Events

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events